Difference between revisions of "Retinoic Acid Derivatives"
Jump to navigation
Jump to search
(Page created) |
m (Protected "Retinoic Acid Derivatives" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
Revision as of 13:22, 19 June 2012
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
A group of drugs used to treat a number of inflammatory conditions, such as acne or psoriasis.
However, they can cause severe congenital defects if given to pregnant women.
Guidance
Generally unacceptable if ever taken Etretinate (Tigason). Allow 12 months after taking acitretin (Neotigason) and 4 weeks after Isotretinoin (Roaccutane).
However, these time periods may be shortened at the discretion of the transplant centre.
Pseudonyms or Related Conditions
Version
Version 1, Edition 1
Date of Last Update
15th June 2012
